ProMIS Neurosciences, Inc.
PMN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $15 | $17 | $24 | $33 |
| - Cash | $15 | $5 | $8 | $13 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$1 | $12 | $16 | $20 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$10 | -$7 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$10 | -$7 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -6 | -7.25 | -5.25 | -0.245 |
| % Growth | 17.2% | -38.1% | -2,042.9% | – |
| Operating Cash Flow | -$10 | -$4 | -$5 | -$8 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$10 | -$4 | -$5 | -$8 |